Prevalence and variations in gastric emptying delay in response to GLP-1 receptor agonist liraglutide

Obesity (Silver Spring). 2024 Feb;32(2):232-233. doi: 10.1002/oby.23941. Epub 2023 Nov 5.

Authors

Michael Camilleri¹, Paula Carlson¹, Saam Dilmaghani¹

Affiliation

¹ Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

PMID: 37927173
PMCID: PMC10841973 (available on 2025-02-01)
DOI: 10.1002/oby.23941

No abstract available

Publication types

Letter

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Diabetes Mellitus, Type 2* / epidemiology
Gastric Emptying / drug effects
Glucagon-Like Peptide-1 Receptor / agonists
Glucagon-Like Peptide-1 Receptor Agonists / adverse effects
Glucagon-Like Peptide-1 Receptor Agonists / pharmacology
Humans
Hypoglycemic Agents / pharmacology
Hypoglycemic Agents / therapeutic use
Liraglutide* / adverse effects
Liraglutide* / pharmacology
Prevalence

Substances

Glucagon-Like Peptide-1 Receptor
Glucagon-Like Peptide-1 Receptor Agonists
Hypoglycemic Agents
Liraglutide

Grants and funding